izvor podataka: crosbi
✓
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia (CROSBI ID 199524)
Prilog u časopisu | Pismo (znanstveno) | međunarodna recenzija
Dujmović, Dino ; Aurer, Igor ; Radman, Ivo ; Serventi-Seiwerth, Ranka ; Dotlić, Snježana ; Štern-Padovan, Ranka ; Dubravčić, Klara ; Šantek, Fedor ; Labar, Boris
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia // Acta haematologica, 127 (2012), 2; 115-117. doi: 10.1159/000334705
Podaci o odgovornosti
Dujmović, Dino ; Aurer, Igor ; Radman, Ivo ; Serventi-Seiwerth, Ranka ; Dotlić, Snježana ; Štern-Padovan, Ranka ; Dubravčić, Klara ; Šantek, Fedor ; Labar, Boris
engleski
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma / leukemia
The paper describes our results in treatment of Burkitt lymphoma / leukemia with rituximab and high-dose methotrexate based chemotherapy.
Burkitt lymphoma; rituximab; methotrexate; combined antineoplastic chemotherapy protocols
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
Povezani projekti
Kliničke medicinske znanosti
Poveznice
Indeksiranost
